glp-1 and cancer treatment Glucagon-like peptide-1 medicines GLP-1 drugs may reduce the

doi: 10.18632/oncotarget.17922 171 XueSHuMLiPMaJXieLTengFet al

The M1 phenotype, stimulated by lipopolysaccharide (LPS) and interferon- (IFN-), was used as a positive control, whereas the M2 phenotype, induced by interleukin-4 (IL-4), functioned as a negative control

The product should not be used by children, pregnant women, and nursing mothers

Advantages: Widely available More affordable than other forms It can be combined with other skin beneficial ingredients like Vitamin C, Collagen, and other antioxidants

Rapid Commun Mass Spectrom

Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor